Eton Pharmaceuticals, Inc.
ETON
$58.83
-$0.52-0.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 54.90% | 14.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 54.90% | 14.03% | |||
| Cost of Revenue | 25.54% | 35.81% | |||
| Gross Profit | 72.77% | 3.88% | |||
| SG&A Expenses | 11.30% | 26.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.29% | 27.87% | |||
| Operating Income | 386.40% | -38.11% | |||
| Income Before Tax | 644.47% | 11.32% | |||
| Income Tax Expenses | 600.00% | 128.99% | |||
| Earnings from Continuing Operations | 645.05% | 4.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 645.05% | 4.79% | |||
| EBIT | 386.40% | -38.11% | |||
| EBITDA | 280.74% | -28.96% | |||
| EPS Basic | 634.91% | 3.45% | |||
| Normalized Basic EPS | 534.01% | -44.39% | |||
| EPS Diluted | 600.00% | -1.38% | |||
| Normalized Diluted EPS | 518.90% | -44.22% | |||
| Average Basic Shares Outstanding | 1.31% | 1.29% | |||
| Average Diluted Shares Outstanding | 3.93% | 0.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||